Global Psoriasis Cases Surpass 100 Million as Tracking Flares Becomes Key to Relief

Over 100 million people globally now live with psoriasis, according to a February 2026 report from the International Federation of Psoriasis Associations (IFPA) and the WHO Foundation. The chronic condition causes painful flares and periods of remission, affecting daily life for millions.

Psoriasis is an inflammatory skin disease marked by red, scaly plaques that can itch, burn, or sting. These symptoms often appear in cycles, with flare-ups followed by calmer phases. Managing the condition focuses on controlling symptoms and extending remission periods.

Tracking flares plays a key role in treatment. Patients can log when symptoms worsen, noting possible triggers like stress, infections, or diet. Recording treatments and their effects helps assess what works best. Measuring the affected body surface area also gives a clearer picture of severity.

For consistent tracking, experts recommend using tools like the 5-point psoriasis symptom scale (PSS) to rate pain and discomfort. Choosing a method that fits personal comfort—whether an app, journal, or digital form—makes monitoring easier. Over time, this data helps prevent future flares and improves long-term management.

The latest figures highlight psoriasis as a widespread yet manageable condition. By logging flares and treatments, patients can better understand their triggers and adjust care plans. This approach aims to reduce symptoms and maintain longer periods without active disease.